U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07025122) titled 'Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease' on Nov. 23, 2024.

Brief Summary: The study is focused on several independent quantifiable biomarkers (sNfL, sGFAP, mitochondrial activity, genetics and fatigue tests) to obtain more detailed information about MS and its progression. Based on the results, investigator will further attempt to predict the course of the disease and manage the therapy more effectively to prevent worsening of the patient's condition.

Study Start Date: Jan. 26, 2024

Study Type: OBSERVATIONAL

Condition: Fatigue in Multiple Sclerosis Multiple ...